LNCTAM34A

Across TCGA pan-cancer cohorts, LNCTAM34A RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated LNCTAM34A data layer.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher LNCTAM34A RNA is associated with better overall survival. In most high-consensus cancer types, elevated LNCTAM34A expression acts as an unfavorable survival marker, although some lineages such as KIRP and UCEC show a favorable association.

KIRP, UCEC, and LGG are the cancer types where LNCTAM34A RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	OS	Tertile	II,III,IV	0.958	0.359	<.001	116	view →
UCEC	OS	Median	All	0.732	0.595	<.001	108	view →
LGG	DFS	Median	All	0.645	0.822	<.001	54	view →
LIHC	OS	Median	III,IV	0.662	0.376	<.001	51	view →
SKCM	OS	Quartile	III,IV	0.715	0.918	<.001	35	view →
LUSC	OS	Median	All	0.732	0.584	<.001	28	view →
READ	DFS	Tertile	II,III,IV	0.815	0.488	.003	28	view →
UCS	OS	Median	All	0.563	0.789	.010	26	view →
UVM	DFS	Tertile	All	0.710	0.483	.013	25	view →
BRCA	DFS	Tertile	IV	0.595	0.191	.018	19	view →
ESCA	DFS	Tertile	All	1.000	0.421	.006	18	view →
THYM	OS	Tertile	All	0.708	0.952	.004	15	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

LNCTAM34A–KIRP (OS)

Open the KIRP breakdown →